Apoptosis/DNA damage Flashcards
Programmed necrosis mechanism
Consumption of NAD+ through PARP-dependent modification –> ADP-ribose
- Leads to NAD+ depeltion and inhibition of glycolysis, no ATP so pump doesn’t work and sodium can’t leave cell, water rushes in and it bursts
IHC to detect apoptosis
best method, antibodies used for specific caspases
propidium iodide and cell sorting to detect apoptosis
PI intercalates DNA and is fluorescent
- DNA content analyzed using flow cytometry
< 2N have lost DNA content due to DNA fragmentation
Annexin V staining
PS found on outer leaflet during apoptosis, stain with antibodies
TUNEL
labeling nicks in DNA
extrinsic pathway ligands
TNFalpha
TRAIL
Fas
unique extrinsic caspase initiators
8, 10
caspase initiators for both intrinsic and extrinsic
2, 9
effector caspases
3, 6, 7
IAPs
IAP1, IAP2, XIAP, Livin
- inhibit effector and initiator caspases
Pro-death Bcl-2 proteins: effectors
BAK and BAX
Pro-death Bcl-2 proteins: BH3- only
BID, BIM, PUMA
BH-3 only activators
BID, BIM, PUMA
- bind and neutralize pro-survival Bcl-2 family members
- promote BAX and BAK oligomerization and pore formation –> cyt c release
BH3-only sensitizers
BAD, BIK, NOXA…. etc
BAX and BAK functions
oligomerize to form pore in mitochondria, release of cyt C
pro-survival Bcl-2 proteins
bind and sequester BAX and BAK
BID
extrinsic, activated in response to death receptors
BIM, PUMA
intrinsic,
BIM activated in response to MT stress
PUMA activated in response to p53
apoptosome
cyt C binds Apaf1, these then bind pro-caspase 9 to cleave and activate it, triggering caspase cascade
5 proteins released from mitochondria
- cyt c: forms apoptosome
- AIF: triggers chromatin condensation, DNA deg, disrupts ETC
- Smac/Diablo: inhibit IAPs
- Omi/HtrA2: inhibit IAPs
- Endo G: endonuclease that cleaves DNA
One of most common events to occur during oncogenesis
upregulation ofNF-kappa B activity: upregulates gene products that block apoptosis
damage by UVB
pyrimidine dimers
damage by UVA
free radicals
ionizing radiation/X rays
DS breaks in DNA strands or SS
polycyclic hydrocarbons
bulky adducts
direct DNA repairs uses…
MGMT
NER
fixes dimers and adducts
BER
uses glycosidase enzymes to remove abnormal bases
NHEJ
- DNA ligase IV, cofactor XRCC4
- can introduce mutations
- no template
HR
- requires template
MMR
- defects cause slippage (HNPCC)
TLS
- last resort, super error prone
- kinda shitty polymerases, but betta than nathan
XP
NER
HNPCC
MMR
MIN
proximal polyp, subtle
familial breast ovarian cancer
DS DNA repair
FA
interstrand crosslink repair/translesional synthesis
Nijmegen Breakage Syndrome
ds DNA repair
NBS1 gene
Li Fraumeni
- mutation in p53 and chk2 genes
AT
ATM gene
Bloom and Werner Syndrome
mutations in RECQ DNA helicase
hyperrecombination
FAP
APC gene
numerous polyps in distal colon, severe
CIN
GFs expressed by cancer cells
PDGF: glioblastomas
HGF: numerous cell types
VEGF: angiogenesis
Receptor tyrosine kinases
HER-2
MET
EGFR
c-KIT
BRAF-V600
seen in melanomas
Gleevac/imatinib
blocks kinase domain of tyrosine kinase
Rituximab
immunotherapy
* antibody against CD20 receptor found on B cells (immunosuppresion)
Tamoxifen
- receptor antagonist for estrogen
* good for bones, bad for endometrium, good for breast ca
Arimidex
hormonal
non-steroidal aromatase inhibitor
Side effects of radiation
Early: mucositis, infertility
Late: fibrosis, secondary cancers
3 common side effects of chemotherapy
alopecia, GI, bone marrow suppression
MDR gene
multi-drug resistance gene, encodes P-glycoprotein, involved in tumor cell resistance to drugs
pumps out chemo drug
how much of tumor mass can be stroma
90% of cells
Two mechanisms for stromal incorporation into tumor
- incorporates pre-existing stroma
2. induces stromal differentiation
xenografts
immunodeficient mice, can’t see stromal contributions
chemical carcinogenesis
carcinogen exposure
implantable murine tumors
line derived from spontaneous cancer in mouse
genetic mouse models
mice develop tumors over time, progressive developmental model similar to humans
chronic inflammatory diseases and cancer susceptibility
Barrett’s esophagus: esophageal
ulcers/gastritis: gastric cancer
IBS: colorectal cancer
TAMs
macrophage, function dysregulated in cancer
MDSCs
myeloid derived suppressor cells
- suppress anti-tumor responses mediated by other immune cells
CAFs
cancer associated fibroblasts
- encourage tumor growth, angiogenesis, inflammation, metastasis
EMT
epidermal to mesenchymal transition
E –> N cadherins, promotion of migration
- upregulate mesenchymal markers
increase in proteolytic enzymes
spindly mesenchymal shape
angiogenesis
new vessels from pre-existing
vasculogenesis
de novo formation of endothelial cells from mesoderm cell precursors
angiogenic switch
can be controlled by hypoxia
MMPs
effector of EMT, good for tumors that want to metastasize
TIMPs
inhibit MMPs
tissue tropism
non-random tissue preference for site of metastasis
CAM use by cancer patients
75% in conjunction with conventional therapy